Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond.
作者信息
Allyse Megan, Chandrasekharan Subhashini
机构信息
Biomedical Ethics Program, Mayo Clinic, Rochester, Minnesota, USA.
Duke Global Health Institute, Duke University, Durham, North Carolina, USA.
出版信息
Genet Med. 2015 Dec;17(12):958-61. doi: 10.1038/gim.2015.23. Epub 2015 Mar 19.
Abstract
摘要
相似文献
1
Too much, too soon?: Commercial provision of noninvasive prenatal screening for subchromosomal abnormalities and beyond.是否过度、过早？：亚染色体异常及其他情况的无创产前筛查商业化服务
Genet Med. 2015 Dec;17(12):958-61. doi: 10.1038/gim.2015.23. Epub 2015 Mar 19.
2
Noninvasive prenatal testing: the importance of pretest trisomy risk and posttest predictive values.
Am J Obstet Gynecol. 2015 Apr;212(4):548-9. doi: 10.1016/j.ajog.2014.12.033. Epub 2014 Dec 30.
3
Microarray analysis: elegant, accurate, and expensive.微阵列分析：优雅、准确且昂贵。
Obstet Gynecol. 2014 Aug;124(2 Pt 1):199-201. doi: 10.1097/AOG.0000000000000407.
4
Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.胎儿染色体异常产前诊断及流产时间的趋势
Am J Obstet Gynecol. 2015 Oct;213(4):545.e1-4. doi: 10.1016/j.ajog.2015.06.008. Epub 2015 Jun 10.
5
Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.基于单核苷酸多态性的高危和低危队列的无创产前筛查。
Obstet Gynecol. 2014 Aug;124(2 Pt 1):210-218. doi: 10.1097/AOG.0000000000000363.
6
Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.无创产前检测在21、18和13三体检测中的临床应用：一家医院的经验。
Prenat Diagn. 2014 Nov;34(11):1061-5. doi: 10.1002/pd.4428. Epub 2014 Jun 29.
7
[Performance and indications of noninvasive prenatal testing using cell free circulating fetal DNA (cffDNA) for the detection of fetal trisomy 21, 18 and 13 in France].[法国使用游离循环胎儿DNA（cffDNA）进行无创产前检测以检测胎儿21三体、18三体和13三体的性能及指征]
J Gynecol Obstet Biol Reprod (Paris). 2016 Jun;45(6):633-40. doi: 10.1016/j.jgyn.2015.08.003. Epub 2015 Oct 27.
8
Increased risk after noninvasive prenatal screening on cell-free DNA circulating in maternal blood: does a new indication for invasive prenatal diagnosis require new criteria for confirmatory cytogenetic analysis?母体血液中游离DNA的无创产前筛查后风险增加：侵入性产前诊断的新指征是否需要用于确诊细胞遗传学分析的新标准？
Prenat Diagn. 2015 Mar;35(3):308-9. doi: 10.1002/pd.4483.
9
The influence of low molecular weight heparin medication on plasma DNA in pregnant women.低分子量肝素用药对孕妇血浆DNA的影响。
Prenat Diagn. 2015 Nov;35(11):1155-7. doi: 10.1002/pd.4668. Epub 2015 Sep 4.
10
Earlier screening for life-threatening conditions in babies.
Community Pract. 2014 Oct;87(10):5.
引用本文的文献
1
Liability, risks, and recommendations for ultrasound use in the diagnosis of obstetrics diseases.超声在产科疾病诊断中的应用的责任、风险及建议。
Heliyon. 2023 Nov 4;9(11):e21829. doi: 10.1016/j.heliyon.2023.e21829. eCollection 2023 Nov.
2
Performance of a universal prenatal screening program incorporating cell-free fetal DNA analysis in Ontario, Canada.加拿大安大略省实施包含游离胎儿 DNA 分析的通用产前筛查计划的效果。
CMAJ. 2021 Aug 3;193(30):E1156-E1163. doi: 10.1503/cmaj.202456.
3
Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants.一项用于检测非整倍体和拷贝数变异的全基因组cfDNA筛查测试的三年临床经验。
Genet Med. 2021 Jul;23(7):1349-1355. doi: 10.1038/s41436-021-01135-8. Epub 2021 Mar 17.
4
Introducing new and emerging genetic tests into prenatal care.将新的和新兴的基因检测引入产前保健。
Semin Perinatol. 2018 Aug;42(5):283-286. doi: 10.1053/j.semperi.2018.07.004. Epub 2018 Jul 26.
5
Online direct-to-consumer messages about non-invasive prenatal genetic testing.关于无创产前基因检测的在线直接面向消费者的信息。
Reprod Biomed Soc Online. 2016 Mar 10;1(2):88-97. doi: 10.1016/j.rbms.2016.02.002. eCollection 2015 Dec.
6
Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.我们是否已进行了最后一次羊膜穿刺术？唐氏综合征筛查中游离DNA检测的最新进展。
Pediatr Radiol. 2018 Apr;48(4):461-470. doi: 10.1007/s00247-017-3958-y. Epub 2018 Mar 17.
7
Toward an Ethically Sensitive Implementation of Noninvasive Prenatal Screening in the Global Context.在全球背景下，实现非侵入性产前筛查的伦理敏感性。
Hastings Cent Rep. 2017 Mar;47(2):41-49. doi: 10.1002/hast.690.
8
Informed decision-making about prenatal cfDNA screening: An assessment of written materials.关于产前cfDNA筛查的知情决策：书面材料评估
Ethics Med Public Health. 2016 Jul-Sep;2(3):362-371. doi: 10.1016/j.jemep.2016.05.004. Epub 2016 Sep 13.
9
Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.基于下一代测序的基因检测的支付方决策：来自游离DNA产前筛查的见解
Genet Med. 2017 May;19(5):559-567. doi: 10.1038/gim.2016.145. Epub 2016 Sep 22.
10
Pre- and post-test genetic counseling for chromosomal and Mendelian disorders.针对染色体疾病和孟德尔遗传病的检测前和检测后遗传咨询。
Semin Perinatol. 2016 Feb;40(1):44-55. doi: 10.1053/j.semperi.2015.11.007. Epub 2015 Dec 21.
本文引用的文献
1
Wrongful birth: clinical settings and legal implications.错误出生：临床情况与法律影响。
Semin Fetal Neonatal Med. 2014 Oct;19(5):312-6. doi: 10.1016/j.siny.2014.08.006. Epub 2014 Sep 1.
2
Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.基于单核苷酸多态性的高危和低危队列的无创产前筛查。
Obstet Gynecol. 2014 Aug;124(2 Pt 1):210-218. doi: 10.1097/AOG.0000000000000363.
3
Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution.微缺失综合征和扩展三体的无创产前检测：谨慎行事。
Obstet Gynecol. 2014 May;123(5):1097-1099. doi: 10.1097/AOG.0000000000000237.
4
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA.利用DNA大规模平行基因组测序技术对孕妇血液进行无创产前筛查，以检测胎儿21三体、18三体、13三体及常见性染色体非整倍体。
Am J Obstet Gynecol. 2014 Oct;211(4):365.e1-12. doi: 10.1016/j.ajog.2014.03.042. Epub 2014 Mar 19.
5
DNA sequencing versus standard prenatal aneuploidy screening.DNA 测序与标准产前非整倍体筛查。
N Engl J Med. 2014 Feb 27;370(9):799-808. doi: 10.1056/NEJMoa1311037.
6
Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing.唐氏综合征患儿母亲对无创产前检测的态度
J Genet Couns. 2014 Oct;23(5):805-13. doi: 10.1007/s10897-014-9694-7. Epub 2014 Feb 1.
7
Next Generation sequencing is the impetus for the next generation of laboratory-based genetic counselors.新一代测序技术是新一代基于实验室的遗传咨询师的推动力。
J Genet Couns. 2014 Aug;23(4):647-54. doi: 10.1007/s10897-013-9684-1. Epub 2014 Jan 17.
8
Ethical and legal aspects of noninvasive prenatal genetic diagnosis.非侵入性产前基因诊断的伦理和法律问题。
Int J Gynaecol Obstet. 2014 Feb;124(2):181-4. doi: 10.1016/j.ijgo.2013.11.001. Epub 2013 Nov 14.
9
Obstetricians and gynecologists' practice and opinions of expanded carrier testing and noninvasive prenatal testing.妇产科医生对扩大携带者检测和无创产前检测的实践与看法。
Prenat Diagn. 2014 Feb;34(2):145-52. doi: 10.1002/pd.4272. Epub 2013 Dec 16.
10
Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing.母体镶嵌是导致与无创性产前检测相关的性染色体非整倍体不一致的重要因素。
Clin Chem. 2014 Jan;60(1):251-9. doi: 10.1373/clinchem.2013.215145. Epub 2013 Nov 5.
Zotero 插件